MedPath

HCG and clomiphene citrate and their effect on semen analysis parameters

Phase 3
Recruiting
Conditions
Male Infertility.
Male infertility
Registration Number
IRCT20180307038986N1
Lead Sponsor
Kermanshah University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Male
Target Recruitment
90
Inclusion Criteria

Severe Oligoasthenospermia
Sperm count less than 5 million
Male infertility

Exclusion Criteria

Male infertility due to a definite etiology
Sever Oligoasthenospermia due to a definite etiology
simultaneously consumption of the drugs that can affect male fertility (Testosterone, Steroids, Cimetidine, ...)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Semen volume, sperm count, the percent of abnormal sperms, the percent of motile sperms. Timepoint: Before the trial, 3 months after trial start. Method of measurement: Semen analysis.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath